http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AR-035688-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d32a49211015b18ecef5a3a5195bf06e |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7061 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-465 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-70 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-465 |
| filingDate | 2002-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2004-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | AR-035688-A1 |
| titleOfInvention | TRANSDERMAL THERAPEUTIC SYSTEM, WITH A NICOTINE CONTENT |
| abstract | Transdermal therapeutic system with a nicotine content, consisting of a backing layer that is not permeable to nicotine, a matrix intermediate layer located immediately adjacent to the backing layer and containing nicotine, another matrix layer containing nicotine, and a layer of redisable protection, the matrix layers being structured with copolymers of (meth) -acrylate, characterized in that the joint thickness of these layers does not exceed 205 microns and the nicotine content is at least 1.5 milligrams per square cm of area of application, which stand out for a particularly high flexibility. Such flexibility decisively improves the comfort of the user who wears them on the skin, since the system can easily adapt to the surface of the skin and its constant movement. Nicotine TTS is manifestly more flexible than nicotine TTS products currently common and prevalent in the market, although at least some of these systems are comparatively thinner. Said transdermal system contains one or more active substances and / or adjuvants that has an effect on the central nervous system. |
| priorityDate | 2001-03-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
| Predicate | Subject |
|---|---|
| isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID89594 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556542 |
Total number of triples: 19.